U.K. defends negotiations with AstraZeneca, BBC News reports
The U.K. government is defending its negotiations with AstraZeneca (AZN), after the pharmaceutical company dropped a planned $558M investment ...
UBS Sticks to Their Hold Rating for AstraZeneca (AZN)
UBS analyst Matthew Weston maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of p11,500.00. The ...